{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:26:30Z","timestamp":1789129590861,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur Le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ctro.2026.101268","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T15:05:15Z","timestamp":1786806315000},"page":"101268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pan-cancer analysis of Notch pathway-linked gene expression identifies tumour-specific and sex-stratified prognostic associations"],"prefix":"10.1016","volume":"61","author":[{"given":"Helen","family":"O'Hea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bourbonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Marignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0005","doi-asserted-by":"crossref","first-page":"17325","DOI":"10.1038\/s41598-019-53799-7","article-title":"Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance","volume":"9","author":"Inder","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ctro.2026.101268_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2016.e00104","article-title":"Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells","volume":"2","author":"Meunier","year":"2016","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.ctro.2026.101268_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17040520","article-title":"Targeting DLL3: innovative strategies for tumor treatment","volume":"17","author":"Wang","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1016\/j.ctro.2026.101268_bb0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/138945010791170860","article-title":"The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness","volume":"11","author":"Wang","year":"2010","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10.1016\/j.ctro.2026.101268_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrc.2016.145","article-title":"Notch as a tumour suppressor","volume":"17","author":"Nowell","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.ctro.2026.101268_bb0040","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.18632\/oncotarget.6714","article-title":"Targeting Notch to overcome radiation resistance","volume":"7","author":"Yahyanejad","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ctro.2026.101268_bb0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s12015-026-11057-0","article-title":"From signaling pathways to combination therapy: bioactive compounds against cancer stem cells","volume":"22","author":"Charan","year":"2026","journal-title":"Stem Cell Rev Rep"},{"issue":"9","key":"10.1016\/j.ctro.2026.101268_bb0050","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/hed.70253","article-title":"AKT, ATR, and Notch inhibitors radiosensitize a preclinical model of adenoid cystic carcinoma","volume":"48","author":"Thoidingjam","year":"2026","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.ctro.2026.101268_bb0055","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s12094-025-03894-1","article-title":"Sex and gender differences in cancer pathogenesis and pharmacology","volume":"27","author":"Bernardez","year":"2025","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ctro.2026.101268_bb0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.physbeh.2017.08.012","article-title":"Applying the new SABV (sex as a biological variable) policy to research and clinical care","volume":"187","author":"Clayton","year":"2018","journal-title":"Physiol Behav"},{"issue":"4","key":"10.1016\/j.ctro.2026.101268_bb0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4062\/biomolther.2018.103","article-title":"Sex differences in cancer: epidemiology, genetics and therapy","volume":"26","author":"Kim","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"issue":"2","key":"10.1016\/j.ctro.2026.101268_bb0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41416-025-03028-y","article-title":"Sex differences in cancer incidence: prospective analyses in the UK Biobank","volume":"133","author":"Khan","year":"2025","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ctro.2026.101268_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11010-023-04723-1","article-title":"Connecting the mechanisms of tumor sex differences with cancer therapy","volume":"479","author":"Li","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ctro.2026.101268_bb0080","article-title":"Gender differences in radiotherapy: a critical review","volume":"215","author":"D\u2019Ippolito","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ctro.2026.101268_bb0085","article-title":"Pan-cancer profiling of ferroptosis-related genes reveals prognostic biomarkers and sex-specific associations","volume":"57","author":"Samuel","year":"2026","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101268_bb0090","article-title":"Biological sex representation and reporting in stereotactic body radiotherapy for kidney cancer: a review of clinical studies","volume":"55","author":"Nwokolo","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0095","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1038\/s41598-024-57771-y","article-title":"In silico analysis of overall survival with YBX1 in male and female solid tumours","volume":"14","author":"Grimes","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13293-020-00291-x","article-title":"Sex differences in cancer mechanisms","volume":"11","author":"Rubin","year":"2020","journal-title":"Biol Sex Differ"},{"issue":"8","key":"10.1016\/j.ctro.2026.101268_bb0105","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrc2675","article-title":"Crosstalk of Notch with p53 and p63 in cancer growth control","volume":"9","author":"Dotto","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.ctro.2026.101268_bb0110","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1177\/1947601911423030","article-title":"Notch signaling in developmental and tumor angiogenesis","volume":"2","author":"Kofler","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ctro.2026.101268_bb0115","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3389\/fimmu.2018.01649","article-title":"Notch signaling as a regulator of the tumor immune response: to target or not to target?","volume":"9","author":"Janghorban","year":"2018","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ctro.2026.101268_bb0120","doi-asserted-by":"crossref","DOI":"10.2196\/27633","article-title":"Web-based survival analysis tool tailored for medical research (KMplot): development and implementation","volume":"23","author":"L\u00e1nczky","year":"2021","journal-title":"J Med Internet Res"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100883","article-title":"Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expression","volume":"14","author":"Vitorino","year":"2021","journal-title":"Transl Oncol"},{"issue":"16","key":"10.1016\/j.ctro.2026.101268_bb0130","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1200\/JCO.22.02823","article-title":"Tarlatamab, a first-in-class DLL3-targeted bispecific T-cell engager, in recurrent small-cell lung cancer: an open-label, phase I study","volume":"41","author":"Paz-Ares","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101268_bb0135","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s12325-025-03136-4","article-title":"Patient-reported outcomes for patients with previously treated small cell lung cancer receiving Tarlatamab: results from the DeLLphi-301 phase 2 trial","volume":"42","author":"Hummel","year":"2025","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3892\/etm.2021.11021","article-title":"miR-130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K\/Akt pathways","volume":"23","author":"Jia","year":"2022","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ctro.2026.101268_bb0145","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.2147\/OTT.S244860","article-title":"The role of DLLs in cancer: a novel therapeutic target","volume":"13","author":"Xiu","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"3","key":"10.1016\/j.ctro.2026.101268_bb0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/gutjnl-2022-327076","article-title":"Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-\u03baB activation in oesophageal adenocarcinoma","volume":"72","author":"Chen","year":"2023","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ctro.2026.101268_bb0155","first-page":"282","article-title":"Up-regulation of DLL1 may promote the chemotherapeutic sensitivity in small cell lung cancer","volume":"16","author":"Liu","year":"2013","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40425-019-0566-4","article-title":"Determinant roles of dendritic cell-expressed notch delta-like and jagged ligands on anti-tumor T cell immunity","volume":"7","author":"Tchekneva","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.1016\/j.ctro.2026.101268_bb0165","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.5114\/aoms.2017.65649","article-title":"Predictive values of Notch signalling in renal carcinoma","volume":"13","author":"J\u0119droszka","year":"2017","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0170","article-title":"SNAI1 promotes epithelial-mesenchymal transition and maintains cancer stem cell-like properties in thymic epithelial tumors through the PIK3R2\/p-EphA2 axis","volume":"43","author":"H","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.ctro.2026.101268_bb0175","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/cas.13997","article-title":"DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail","volume":"110","author":"Furuta","year":"2019","journal-title":"Cancer Sci"},{"issue":"7","key":"10.1016\/j.ctro.2026.101268_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101080","article-title":"High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients","volume":"14","author":"Yuan","year":"2021","journal-title":"Transl Oncol"},{"issue":"D1","key":"10.1016\/j.ctro.2026.101268_bb0185","doi-asserted-by":"crossref","first-page":"D1016","DOI":"10.1093\/nar\/gkae1080","article-title":"Harmonizome 3.0: integrated knowledge about genes and proteins from diverse multi-omics resources","volume":"53","author":"Diamant","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ctro.2026.101268_bb0190","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw100","article-title":"The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins","volume":"2016","author":"Rouillard","year":"2016","journal-title":"Database"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0195","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1186\/s12885-019-6396-4","article-title":"The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo","volume":"19","author":"Weber","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2026.101268_bb0200","article-title":"Exosomal lncRNA SCIRT\/miR-665 transferring promotes lung cancer cell metastasis through the inhibition of HEYL","volume":"2021","author":"Wang","year":"2021","journal-title":"J Oncol"},{"key":"10.1016\/j.ctro.2026.101268_bb0205","article-title":"HEYL regulates neoangiogenesis through overexpression in both breast tumor epithelium and endothelium","volume":"10","author":"Han","year":"2020","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101268_bb0210","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10388-025-01147-2","article-title":"HEYL-mediated activation of LAMA3 influences radiotherapy response in esophageal cancer","volume":"22","author":"Tang","year":"2025","journal-title":"Esophagus"},{"issue":"14","key":"10.1016\/j.ctro.2026.101268_bb0215","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.18632\/aging.206021","article-title":"Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer","volume":"16","author":"Wang","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ctro.2026.101268_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.725024","article-title":"Construction and validation of a 15-top-prognostic-gene-based signature to indicate the dichotomized clinical outcome and response to targeted therapy for bladder cancer patients","volume":"10","author":"Gu","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0225","article-title":"Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma","volume":"17","author":"Liu","year":"2024","journal-title":"BMC Med Genet"},{"issue":"4","key":"10.1016\/j.ctro.2026.101268_bb0230","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2018.01.002","article-title":"Dynamic ligand discrimination in the Notch signaling pathway","volume":"172","author":"Nandagopal","year":"2018","journal-title":"Cell"},{"issue":"1 Pt 3","key":"10.1016\/j.ctro.2026.101268_bb0235","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.gene.2015.10.065","article-title":"Jagged1 (JAG1): structure, expression, and disease associations","volume":"576","author":"Grochowski","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.ctro.2026.101268_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110416","article-title":"The oncogenic role of Jagged1\/Notch signaling in cancer","volume":"129","author":"Xiu","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.ctro.2026.101268_bb0245","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.advms.2022.04.001","article-title":"Anti-Jagged-1 immunotherapy in cancer","volume":"67","author":"Pancewicz","year":"2022","journal-title":"Adv Med Sci"},{"issue":"3","key":"10.1016\/j.ctro.2026.101268_bb0250","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jjco\/hyq205","article-title":"High Jagged1 expression predicts poor outcome in clear cell renal cell carcinoma","volume":"41","author":"Wu","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101268_bb0255","article-title":"Prognostic signatures and therapeutic value based on the Notch pathway in renal clear cell carcinoma","volume":"2022","author":"Li","year":"2022","journal-title":"Oxidative Med Cell Longev"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yexcr.2017.01.022","article-title":"miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1\/Notch2 pathway stimulating EMT","volume":"352","author":"Chen","year":"2017","journal-title":"Exp Cell Res"},{"issue":"6","key":"10.1016\/j.ctro.2026.101268_bb0265","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/modpathol.3800785","article-title":"High-level JAG1 mRNA and protein predict poor outcome in breast cancer","volume":"20","author":"Dickson","year":"2007","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.ctro.2026.101268_bb0270","article-title":"Gender disparity in host responses to hepatitis B-related hepatocellular carcinoma: a case series","volume":"9","author":"Bashir Hamidu","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13293-024-00641-z","article-title":"Sex-specific associations of Notch signaling with chronic HBV infection: a study from Taiwan Biobank","volume":"15","author":"Jen","year":"2024","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.ctro.2026.101268_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111159","article-title":"Evaluation of the association between sex-linked genes and treatment response in lung cancer","volume":"212","author":"Kinsella","year":"2025","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101268_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150355","article-title":"JAG1 is associated with poor survival through inducing metastasis in lung cancer","volume":"11","author":"Chang","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ctro.2026.101268_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110492","article-title":"Tumor-derived Jagged1 promotes cancer progression through immune evasion","volume":"38","author":"Meng","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.ctro.2026.101268_bb0295","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13287-020-01679-7","article-title":"MiR-153 reduces stem cell-like phenotype and tumor growth of lung adenocarcinoma by targeting Jagged1","volume":"11","author":"Zhao","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"26","key":"10.1016\/j.ctro.2026.101268_bb0300","doi-asserted-by":"crossref","first-page":"22006","DOI":"10.18632\/oncotarget.4292","article-title":"MicroRNA-153\/Nrf-2\/GPx1 pathway regulates radiosensitivity and stemness of glioma stem cells via reactive oxygen species","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ctro.2026.101268_bb0305","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3892\/ol.2021.12561","article-title":"miR-153 enhances the therapeutic effect of radiotherapy by targeting JAG1 in pancreatic cancer cells","volume":"21","author":"Zhao","year":"2021","journal-title":"Oncol Lett"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:23:33Z","timestamp":1789125813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":61,"alternative-id":["S2405630826001631"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101268","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pan-cancer analysis of Notch pathway-linked gene expression identifies tumour-specific and sex-stratified prognostic associations","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101268"}}